Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-1304P (RNA, U6 small nuclear 1304, pseudogene)** is a processed pseudogene found on chromosome 1 at cytogenetic band 1q42.12. Pseudogenes are remnants of functional genes that have lost their protein-coding capability due to mutations or truncation. Typically, U6 small nuclear RNA is involved in splicing as a component of the spliceosome, but as a pseudogene, RNU6-1304P does not produce a functional product. Although some pseudogenes can be transcribed and act as regulatory lncRNAs, no specific function or disease link has been demonstrated for RNU6-1304P[3][4][6][7]. It is not considered a receptor, enzyme, transporter, or therapeutic target. Key points: - RNU6-1304P is a noncoding, non-functional genomic locus related to U6 small nuclear RNA[3][7]. - It is not a drug target, biomarker, or disease gene, and is classified as a pseudogene. - No safety concerns or clinical relevance have been reported.
No drugs target this pseudogene; general mechanisms for pseudogenes as lncRNAs may include microRNA sponging or modulation of chromatin
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1304, pseudogene (RNU6-1304P).